Structure-based modeling of the functional HIV-1 intasome and its inhibition

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 36, 2010, Pages 15910-15915

  Krishnan, Lavanya ^a   Li, Xiang ^a   Naraharisetty, Hema L ^a   Hare, Stephen ^b   Cherepanov, Peter ^b   Engelman, Alan ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Drug resistance; HIV AIDS; Integrase; Integration; Raltegravir

Indexed keywords

DNA; INTEGRASE;

ARTICLE; DNA BINDING; DNA DETERMINATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; SPUMA VIRUS; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS RESISTANCE; CHEMISTRY; HUMAN; PHYSIOLOGY; PROTEIN CONFORMATION; THEORETICAL MODEL;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS;

HIV-1; HUMANS; MODELS, THEORETICAL; PROTEIN CONFORMATION;

EID: 77957670046     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1002346107     Document Type: Article

References (54)

1. Engelman A (2010) Reverse transcription and integration. Retroviruses: Molecular Biology, Genomics and Pathogenesis, eds Kurth R, Bannert N (Caister Academic Press, Norfolk, United Kingdom), pp 129-159.
2. Dyda F, et al. (1994) Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science 266:1981-1986.
3. Davies DR, Goryshin IY, Reznikoff WS, Rayment I (2000) Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science 289:77-85.
4. Richardson JM, Colloms SD, Finnegan DJ, Walkinshaw MD (2009) Molecular architecture of the Mos1 paired-end complex: The structural basis of DNA transposition in a eukaryote. Cell 138:1096-1108.
5. Farnet CM, Bushman FD (1997) HIV-1 cDNA integration: Requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88:483-492.
6. Wei S-Q, Mizuuchi K, Craigie R (1997) A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J 16:7511-7520.
7. Chen H, Wei S-Q, Engelman A (1999) Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome. J Biol Chem 274:17358-17364. (Pubitemid 29275203)
8. Li M, Mizuuchi M, Burke TRJ, Jr, Craigie R (2006) Retroviral DNA integration: Reaction pathway and critical intermediates. EMBO J 25:1295-1304.
9. Miller MD, Farnet CM, Bushman FD (1997) Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition. J Virol 71: 5382-5390.
10. Chen H, Engelman A (2001) Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: Implications for functional end coupling during the chemical steps of DNA transposition. Mol Cell Biol 21:6758-6767.
11. Pandey KK, et al. (2007) Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate. J Virol 81:12189-12199.
12. Summa V, et al. (2008) Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. J Med Chem 51: 5843-5855.
13. McColl DJ, Chen X (2010) Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy. Antiviral Res 85:101-118.
14. Wang J-Y, Ling H, Yang W, Craigie R (2001) Structure of a two-domain fragment of HIV-1 integrase: Implications for domain organization in the intact protein. EMBO J 20:7333-7343.
15. Chen JC-H, et al. (2000) Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding. Proc Natl Acad Sci USA 97:8233-8238.
16. Espeseth AS, et al. (2000) HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc Natl Acad Sci USA 97:11244-11249.
17. Chen Z, et al. (2000) X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293) - an initial glance of the viral DNA binding platform. J Mol Biol 296:521-533.
18. Yang Z-N, Mueser TC, Bushman FD, Hyde CC (2000) Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. J Mol Biol 296:535-548.
19. Hare S, et al. (2009) Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathog 5:e1000515.
20. Gao K, Butler SL, Bushman F (2001) Human immunodeficiency virus type 1 integrase: Arrangement of protein domains in active cDNA complexes. EMBO J 20:3565-3576.
21. Wielens J, Crosby IT, Chalmers DK (2005) A three-dimensional model of the human immunodeficiency virus type 1 integration complex. J Comput Aided Mol Des 19:301-317.
22. Chen A, Weber IT, Harrison RW, Leis J (2006) Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat ends. J Biol Chem 281:4173-4182.
23. Chen X, et al. (2008) Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors. J Mol Biol 380:504-519.
24. Zhao Z, et al. (2008) Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding. J Biol Chem 283:5632-5641.
25. Michel F, et al. (2009) Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor. EMBO J 28:980-991.
26. Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P (2010) Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464:232-236.
27. Alian A, et al. (2009) Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs. Proc Natl Acad Sci USA 106:8192-8197.
28. Savarino A (2007) In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate. Retrovirology 4:21.
29. Jenkins TM, Esposito D, Engelman A, Craigie R (1997) Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J 16:6849-6859.
30. Esposito D, Craigie R (1998) Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J 17:5832-5843.
31. Johnson AA, et al. (2006) Integration requires a specific interaction of the donor DNA terminal 5′-cytosine with glutamine 148 of the HIV-1 integrase flexible loop. J Biol Chem 281:461-467.
32. Heuer TS, Brown PO (1997) Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking. Biochemistry 36:10655-10665.
33. Khan E, Mack JP, Katz RA, Kulkosky J, Skalka AM (1991) Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res 19:851-860.
34. Terzian C, Ferraz C, Demaille J, Bucheton A (2000) Evolution of the Gypsy endogenous retrovirus in the Drosophila melanogaster subgroup. Mol Biol Evol 17:908-914.
35. Hobaika Z, et al. (2009) Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase alpha4 helix. Nucleic Acids Res 37:7691-7700.
36. Lutzke RA, Plasterk RH (1998) Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: Critical residues for protein oligomerization and DNA binding. J Virol 72:4841-4848.
37. Nowotny M, Gaidamakov SA, Crouch RJ, Yang W (2005) Crystal structures of RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis. Cell 121:1005-1016.
38. Grobler JA, et al. (2002) Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes. Proc Natl Acad Sci USA 99:6661-6666.
39. Barreca ML, Iraci N, De Luca L, Chimirri A (2009) Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem 4:1446-1456.
40. Perryman AL, et al. (2010) A dynamic model of HIV integrase inhibition and drug resistance. J Mol Biol 397:600-615.
41. Valkov E, et al. (2009) Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res 37:243-255.
42. Langley DR, et al. (2008) The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors. Biochemistry 47:13481-13488.
43. Morris GM, et al. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30:2785-2791.
44. Metifiot M, Marchand C, Maddali K, Pommier Y (2010) Resistance to integrase inhibitors. Viruses 2:1347-1366.
45. Kobayashi M, et al. (2008) Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants. Antiviral Res 80: 213-222.
46. Fransen S, et al. (2009) Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. J Virol 83: 11440-11446.
47. Delelis O, et al. (2010) Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo. Antimicrob Agents Chemother 54:491-501.
48. Shimura K, et al. (2008) Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol 82:764-774.
49. Delelis O, et al. (2009) The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation. Nucleic Acids Res 37:1193-1201.
50. van Gent DC, Vink C, Groeneger AA, Plasterk RH (1993) Complementation between HIV integrase proteins mutated in different domains. EMBO J 12:3261-3267.
51. Engelman A, Bushman FD, Craigie R (1993) Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J 12:3269-3275.
52. Faure A, et al. (2005) HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res 33:977-986. (Pubitemid 41430518)
53. Guiot E, et al. (2006) Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity. J Biol Chem 281:22707-22719.
54. Bosserman MA, O'Quinn DF, Wong I (2007) Loop202-208 in avian sarcoma virus integrase mediates tetramer assembly and processing activity. Biochemistry 46: 11231-11239.